Companies Molina Healthcare
Molina Healthcare (MOH): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Molina Healthcare’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers40th pct.Of 16 peer CEOs
CEO pay, last three years
- $21,491,723FY2023
- $21,944,109FY2024
- $18,340,783FY2025
CEO total pay was $18,340,783 in fiscal 2025, down from $21,944,109 in fiscal 2024.
FY2025: salary $1,600,000 · bonus $0 · stock awards $16,199,988 · option awards $0
Executives and directors
Jeff Barlow · General CounselJoseph Zubretsky · CEOMark Keim · CFODebra Bacon · EVPJames Woys · COOBarbara L. Brasier · Independent DirectorDale B. Wolf · Chair of the BoardDaniel Cooperman · Former director (through FY2025)Francis S. Soistman · Independent DirectorLeo P. Grohowski · Independent DirectorRichard C. Zoretic · Independent DirectorRichard M. Schapiro · Independent DirectorRonna E. Romney · Independent DirectorStephen H. Lockhart · Independent DirectorSteven J. Orlando · Independent Director
Frequently asked questions
Who was the highest-paid executive at Molina Healthcare in fiscal 2025?
As disclosed, Joseph Zubretsky (President and Chief Executive Officer) was the highest-paid executive at Molina Healthcare in fiscal 2025, with total compensation of $18,340,783.
How does Molina Healthcare's chief executive pay compare to its disclosed peer group?
As disclosed, Joseph Zubretsky's total compensation ranked at the 40th percentile of Molina Healthcare's disclosed peer group.
What is Molina Healthcare's CEO-to-median employee pay ratio?
As disclosed, Molina Healthcare's CEO-to-median employee pay ratio was 228:1.
How did shareholders vote on Molina Healthcare's executive compensation?
As disclosed, 52.75% of shareholders supported Molina Healthcare's executive compensation in the latest say-on-pay vote.
How much does Molina Healthcare spend in total on board compensation for fiscal 2025?
As disclosed, Molina Healthcare reported total board compensation of $3,319,268 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Joseph Zubretsky | $1,600,000 | $0 | $16,199,988 | $0 | $0 | $0 | $540,795 | $18,340,783 |
| President and Chief Executive Officer | ||||||||
| Mark Keim | 1,000,000 | 0 | 6,250,135 | 0 | 0 | 0 | 312,049 | 7,562,184 |
| Chief Financial Officer | ||||||||
| James Woys | 800,000 | 0 | 4,500,109 | 0 | 0 | 0 | 56,409 | 5,356,518 |
| Chief Operating Officer | ||||||||
| Jeff Barlow | 685,000 | 0 | 3,500,053 | 0 | 0 | 159,234 | 51,037 | 4,395,324 |
| Chief Legal Officer and Secretary | ||||||||
| Debra Bacon | 675,000 | 0 | 2,200,066 | 0 | 0 | 8,630 | 48,031 | 2,931,727 |
| Executive Vice President, Medicaid | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Joseph Zubretsky | $18,340,783 | $21,944,109 | $21,491,723 | ↓ −3,603,326 |
| Mark Keim | 7,562,184 | 7,045,869 | 6,402,049 | ↑ +516,315 |
| James Woys | 5,356,518 | 6,196,657 | 5,537,101 | ↓ −840,139 |
| Jeff Barlow | 4,395,324 | 4,830,168 | 4,889,102 | ↓ −434,844 |
| Debra Bacon | 2,931,727 | 3,636,123 | — | ↓ −704,396 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company endeavors to pay its management team competitively within the marketplace in a manner that would ensure personnel are properly motivated to increase profitability and stockholder value. To that end, consistent with our overarching pay-for-performance philosophy, we are targeting total compensation opportunities for the Company s executives within a reasonable range of the median relative to peer executives, with actual compensation set below median when performance is below target, at median for median performance, and above median when warranted by strong performance.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Mark Keim | PSU | 2025-03-01 | 6,508 | 13,016 | — | 26,032 | $3,750,139 |
| Debra Bacon | RSU | 2025-03-01 | — | — | 3,054 | — | 879,911 |
| Joseph Zubretsky | RSU | 2025-03-01 | — | — | 22,491 | — | 6,480,053 |
| Mark Keim | RSU | 2025-03-01 | — | — | 8,677 | — | 2,499,996 |
| Jeff Barlow | RSU | 2025-03-01 | — | — | 4,859 | — | 1,399,964 |
| James Woys | RSU | 2025-03-01 | — | — | 6,248 | — | 1,800,159 |
| Jeff Barlow | PSU | 2025-03-01 | 3,645 | 7,289 | — | 14,578 | 2,100,089 |
| Debra Bacon | PSU | 2025-03-01 | 2,291 | 4,582 | — | 9,164 | 1,320,155 |
| James Woys | PSU | 2025-03-01 | 4,686 | 9,371 | — | 18,742 | 2,699,950 |
| Joseph Zubretsky | PSU | 2025-03-01 | 16,868 | 33,736 | — | 67,472 | 9,719,935 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Mark Keim | $2,499,996 | $3,750,139 | $0 | 60.0% |
| Debra Bacon | 879,911 | 1,320,155 | 0 | 60.0% |
| Joseph Zubretsky | 6,480,053 | 9,719,935 | 0 | 60.0% |
| Jeff Barlow | 1,399,964 | 2,100,089 | 0 | 60.0% |
| James Woys | 1,800,159 | 2,699,950 | 0 | 60.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Debra Bacon | RSU | 245 | — | $42,517 |
| Debra Bacon | RSU | 529 | — | 91,803 |
| Debra Bacon | PSU | 735 | — | 63,776 |
| Jeff Barlow | RSU | 1,461 | — | 253,542 |
| Debra Bacon | RSU | 1,515 | — | 262,913 |
| James Woys | RSU | 1,704 | — | 295,712 |
| Mark Keim | RSU | 1,948 | — | 338,056 |
| Jeff Barlow | RSU | 2,204 | — | 382,482 |
| Debra Bacon | PSU | 2,385 | — | 206,946 |
| Debra Bacon | RSU | 3,054 | — | 529,991 |
| James Woys | RSU | 3,099 | — | 537,801 |
| Debra Bacon | PSU | 3,409 | — | 295,799 |
| Mark Keim | RSU | 3,443 | — | 597,498 |
| Debra Bacon | PSU | 4,582 | — | 397,580 |
| Jeff Barlow | RSU | 4,859 | — | 843,231 |
| Jeff Barlow | PSU | 4,958 | — | 430,206 |
| James Woys | RSU | 6,248 | — | 1,084,278 |
| Jeff Barlow | PSU | 6,574 | — | 570,426 |
| James Woys | PSU | 6,973 | — | 605,047 |
| Jeff Barlow | PSU | 7,289 | — | 632,466 |
| Joseph Zubretsky | RSU | 7,548 | — | 1,309,880 |
| James Woys | PSU | 7,670 | — | 665,526 |
| Mark Keim | PSU | 7,748 | — | 672,294 |
| Mark Keim | RSU | 8,677 | — | 1,505,807 |
| Mark Keim | PSU | 8,765 | — | 760,539 |
| James Woys | PSU | 9,371 | — | 813,122 |
| Joseph Zubretsky | RSU | 11,156 | — | 1,936,012 |
| Mark Keim | PSU | 13,016 | — | 1,129,398 |
| Joseph Zubretsky | RSU | 22,491 | — | 3,903,088 |
| Joseph Zubretsky | PSU | 25,103 | — | 2,178,187 |
| Joseph Zubretsky | PSU | 33,736 | — | 2,927,273 |
| Joseph Zubretsky | PSU | 33,967 | — | 2,947,317 |
| Mark Keim | PSU | 82,603 | — | 2,562,231 |
| Joseph Zubretsky | PSU | 238,990 | — | 8,052,777 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Dale B. WolfIndependent · Board Chair · Compensation (Chair) · Corporate Governance & Nominating · Finance | $430,000 | $220,141 | $0 | $0 | $0 | $650,141 |
| Ronna E. RomneyIndependent · Compensation · Corporate Governance & Nominating (Chair) | 190,000 | 220,141 | 0 | 0 | 0 | 410,141 |
| Steven J. OrlandoIndependent · Audit (Chair & Financial Expert) · Corporate Governance & Nominating · Finance | 185,000 | 220,141 | 0 | 0 | 0 | 405,141 |
| Richard M. SchapiroIndependent · Audit · Finance (Chair) | 162,500 | 220,141 | 0 | 0 | 0 | 382,641 |
| Richard C. ZoreticIndependent · Audit · Compliance and Quality (Chair) | 159,203 | 220,141 | 0 | 0 | 0 | 379,344 |
| Barbara L. BrasierIndependent · Audit (Financial Expert) · Compensation | 152,500 | 220,141 | 0 | 0 | 0 | 372,641 |
| Stephen H. LockhartIndependent · Compliance and Quality | 137,500 | 220,141 | 0 | 0 | 0 | 357,641 |
| Leo P. GrohowskiIndependent · Compensation · Compliance and Quality · Newly elected | 92,170 | 147,016 | 0 | 0 | 0 | 239,186 |
| Daniel CoopermanIndependent · Departed during FY | 49,032 | 73,360 | 0 | 0 | 0 | 122,392 |
| Francis S. SoistmanIndependent · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Joseph M. ZubretskyEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $220,000 |
| Per board meeting fee | $1,000 |
| Committee chair fees (audit / comp / nom-gov) | 32,500 / 22,500 / 22,500 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,557,905 |
| Equity awards (grant-date value) | $1,761,363 |
| All other compensation | $0 |
| Total cost of the board | $3,319,268 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Molina Healthcare as a peer
Companies that benchmark against MOH
11 companies name MOH as a compensation peer
- Archer-Daniels-Midland CoADMFY2025
- BrightSpring Health Services, Inc.BTSGFY2025
- CENTENE CORPCNCFY2025
- COMMUNITY HEALTH SYSTEMS INCCYHFY2025
- CVS HEALTH CorpCVSFY2025
- DAVITA INC.DVAFY2025
- HCA Healthcare, Inc.HCAFY2025
- HUMANA INCHUMFY2025
- PROGRESSIVE CORP/OH/PGRFY2025
- UNIVERSAL HEALTH SERVICES INCUHSFY2025
Each company listed discloses MOH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MOH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
UHS Universal Health Services, Inc.PRU Prudential Financial, Inc. Laboratory Corporation of America HoldingsHUM Humana, Inc.DGX Quest Diagnostics IncorporatedBSX Boston Scientific CorporationAFL Aflac IncorporatedBDX Becton, Dickinson and CompanyCNC Centene CorporationCYH Community Health Systems, Inc.DVA DaVita Inc.ELV Elevance Health, Inc.HCA HCA Healthcare, Inc.MET MetLife, Inc.THC Tenet Healthcare CorporationCI The Cigna Group
Peer reciprocity
The companies Molina Healthcare names as compensation peers that name it back in their own disclosed peer groups.
Universal Health Services, Inc. (UHS)83Humana, Inc. (HUM)84Centene Corporation (CNC)85Community Health Systems, Inc. (CYH)86DaVita Inc. (DVA)87HCA Healthcare, Inc. (HCA)88The Cigna Group (CI)89
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Tenet Healthcare Corporation | 2025 | Saum Sutaria | $1,500,000 | $31,677,365 | $0 | $9,000,000 | $43,108,969 |
| 2 | HCA Healthcare, Inc. | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 3 | Aflac Incorporated | 2025 | Daniel Amos | 1,441,100 | 11,340,782 | 0 | 6,350,193 | 25,033,687 |
| 4 | Boston Scientific Corporation | 2025 | Michael Mahoney | 1,442,603 | 13,608,056 | 3,749,980 | 4,002,001 | 23,532,050 |
| 5 | The Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 6 | Elevance Health, Inc. | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 7 | MetLife, Inc. | 2025 | Michel Khalaf | 1,500,000 | 14,797,601 | 0 | 4,600,000 | 22,364,273 |
| 8 | Centene Corporation | 2025 | Sarah London | 1,473,077 | 15,537,733 | 0 | 2,109,446 | 19,506,298 |
| 9 | Humana, Inc. | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 10 | Molina Healthcare | 2025 | Joseph Zubretsky | 1,600,000 | 16,199,988 | 0 | 0 | 18,340,783 |
| 11 | DaVita Inc. | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 12 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 13 | Universal Health Services, Inc. | 2025 | Marc Miller | 1,430,769 | 9,999,904 | 0 | 4,292,307 | 16,148,937 |
| 14 | Quest Diagnostics Incorporated | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 15 | Prudential Financial, Inc. | 2025 | Andrew Sullivan | 1,089,205 | 4,618,266 | 0 | 4,664,000 | 11,408,423 |
| 16 | Community Health Systems, Inc. | 2025 | Kevin Hammons | 927,194 | 812,700 | 204,300 | 1,746,642 | 4,772,869 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Molina Healthcare | not disclosed | PSU 60 · RSU 40 | No | FW Cook |
| Aflac Incorporated | not disclosed | PSU 100 | No | Mercer (US) LLC |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Boston Scientific Corporation | 173% | PSU 50 · RSU 25 · Options 25 | No | Semler Brossy Consulting Group, LLC |
| Centene Corporation | 71.6% | PSU 60 · RSU 40 | Yes — Relative TSR | FW Cook |
| Community Health Systems, Inc. | not disclosed | PSU 75 · Option 25 | not disclosed | Mercer |
| DaVita Inc. | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Elevance Health, Inc. | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| HCA Healthcare, Inc. | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Humana, Inc. | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| MetLife, Inc. | 100.5% | PSU 70 · RSU 30 | Yes — TSR relative to TSR Peer Group | Meridian Compensation Partners, LLC |
| Prudential Financial, Inc. | 106% | PSU 75 · RSU 25 | No | FW Cook |
| Quest Diagnostics Incorporated | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| Tenet Healthcare Corporation | 200% | PSU 60 · RSU 40 | No | Meridian Compensation Partners, LLC |
| The Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Universal Health Services, Inc. | 200% | RSU 50 · PSU 50 | No | FW Cook |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-06 | 22,459,321 | 20,116,888 | 51,307 | 52.75% | Passed |
| 2025 | 2025-04-30 | 18,249,700 | 26,653,672 | 66,546 | 40.64% | Failed |
| 2024 | 2024-05-01 | 46,266,687 | 3,277,670 | 32,093 | 93.38% | Passed |
| 2023 | 2023-05-03 | 44,548,396 | 7,888,118 | 13,270 | 84.96% | Passed |
| 2022 | 2022-05-04 | 48,981,043 | 2,410,155 | 14,566 | 95.31% | Passed |
| 2021 | 2021-05-06 | 50,939,394 | 639,286 | 20,369 | 98.76% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-06 | 52.75%a |
| 2025 | 2025-04-30 | 40.64%b |
| 2024 | 2024-05-01 | 93.38%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes are not considered votes cast or shares entitled to vote with respect to this proposal and therefore will have no effect on the outcome of Proposal 2.”.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 228 : 1 |
|---|---|
| CEO total compensation | $18,340,783 |
| Median employee compensation | $80,329 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Ronna E. Romney | Director | 2026-04-01 | A | 405 | $136 | $55,007 | Common | Form 4 ↗ |
| Barbara L. Brasier | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Richard C. Zoretic | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Stephen H. Lockhart | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Dale B. Wolf | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Leo P. Grohowski | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Steven J. Orlando | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Richard M. Schapiro | Director | 2026-04-01 | A | 405 | 136 | 55,007 | Common | Form 4 ↗ |
| Francis S. Soistman | Director | 2026-05-06 | A | 170 | 197 | 33,565 | Common | Form 4 ↗ |
| Jeff Barlow | Chief Legal Officer | 2026-05-11 | D | 17,811 | 186 | 3,314,983 | Common | Form 4 ↗ |
| Maurice Hebert | Chief Accounting Officer | 2026-05-14 | D | 600 | 192 | 114,930 | Common | Form 4 ↗ |
| Debra Bacon | EVP, Medicaid | 2026-06-30 | A | 23 | 148 | 3,393 | Common | Form 4 ↗ |
| Jeff Barlow | Chief Legal Officer | 2026-06-30 | A | 138 | 148 | 20,356 | Common | Form 4 ↗ |
| James Woys | Chief Operating Officer | 2026-06-30 | A | 144 | 148 | 21,241 | Common | Form 4 ↗ |
| Ronna E. Romney | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Richard C. Zoretic | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Steven J. Orlando | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Richard M. Schapiro | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Debra Bacon | EVP, Medicaid | 2026-07-01 | D | 183 | 233 | 42,557 | Common | Form 4 ↗ |
| Barbara L. Brasier | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Leo P. Grohowski | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Stephen H. Lockhart | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Dale B. Wolf | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Francis S. Soistman | Director | 2026-07-01 | A | 237 | 233 | 55,114 | Common | Form 4 ↗ |
| Richard C. Zoretic | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Dale B. Wolf | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Francis S. Soistman | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Richard M. Schapiro | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Stephen H. Lockhart | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Ronna E. Romney | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Steven J. Orlando | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Leo P. Grohowski | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
| Barbara L. Brasier | Director | 2026-10-01 | A | 304 | 181 | 54,978 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (89 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Joseph Zubretsky. DEF 14A, filed 2026-03-23. Section “2025 Summary Compensation Table” · page 47. As printed: 18,340,783. View filing ↗
- Section 01, Mark Keim. DEF 14A, filed 2026-03-23. Section “2025 Summary Compensation Table” · page 47. As printed: 7,562,184. View filing ↗
- Section 01, James Woys. DEF 14A, filed 2026-03-23. Section “2025 Summary Compensation Table” · page 47. As printed: 5,356,518. View filing ↗
- Section 01, Jeff Barlow. DEF 14A, filed 2026-03-23. Section “2025 Summary Compensation Table” · page 47. As printed: 4,395,324. View filing ↗
- Section 01, Debra Bacon. DEF 14A, filed 2026-03-23. Section “2025 Summary Compensation Table” · page 47. As printed: 2,931,727. View filing ↗
- Section 03, Mark Keim PSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Debra Bacon RSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Joseph Zubretsky RSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Keim RSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Jeff Barlow RSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, James Woys RSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Jeff Barlow PSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Debra Bacon PSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, James Woys PSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Joseph Zubretsky PSU. DEF 14A, filed 2026-03-23. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-23. Section “CEO Pay Ratio”. As printed: 228 : 1. View filing ↗
- Section 08, Dale B. Wolf. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 650,141. View filing ↗
- Section 08, Ronna E. Romney. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 410,141. View filing ↗
- Section 08, Steven J. Orlando. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 405,141. View filing ↗
- Section 08, Richard M. Schapiro. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 382,641. View filing ↗
- Section 08, Richard C. Zoretic. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 379,344. View filing ↗
- Section 08, Barbara L. Brasier. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 372,641. View filing ↗
- Section 08, Stephen H. Lockhart. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 357,641. View filing ↗
- Section 08, Leo P. Grohowski. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 239,186. View filing ↗
- Section 08, Daniel Cooperman. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 122,392. View filing ↗
- Section 08, Francis S. Soistman. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Joseph M. Zubretsky. DEF 14A, filed 2026-03-23. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Ronna E. Romney 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Barbara L. Brasier 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard C. Zoretic 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen H. Lockhart 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dale B. Wolf 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leo P. Grohowski 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Steven J. Orlando 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard M. Schapiro 2026-04-01. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman 2026-05-06. Form 4, filed 2026-05-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeff Barlow 2026-05-11. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Maurice Hebert 2026-05-14. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Debra Bacon 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeff Barlow 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James Woys 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronna E. Romney 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard C. Zoretic 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Steven J. Orlando 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard M. Schapiro 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Debra Bacon 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Barbara L. Brasier 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leo P. Grohowski 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen H. Lockhart 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dale B. Wolf 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard C. Zoretic 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dale B. Wolf 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francis S. Soistman 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard M. Schapiro 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen H. Lockhart 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronna E. Romney 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Steven J. Orlando 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leo P. Grohowski 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Barbara L. Brasier 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-11. Item 5.07 · say-on-pay result. As reported: 52.75% (votes for as printed: 22,459,321). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-01. Item 5.07 · say-on-pay result. As reported: 40.64% (votes for as printed: 18,249,700). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-03. Item 5.07 · say-on-pay result. As reported: 93.38% (votes for as printed: 46,266,687). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,557,905 + equity 1,761,363 + all other 0 = 3,319,268, summed across the director compensation table rows.
- Tenet Healthcare Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in Tenet Healthcare Corporation's own proxy. As printed: 43,108,969. View filing ↗
- HCA Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. View filing ↗
- Aflac Incorporated, Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in Aflac Incorporated's own proxy. As printed: 25,033,687. View filing ↗
- Boston Scientific Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. View filing ↗
- The Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
- Elevance Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health, Inc.'s own proxy. As printed: 22,582,314. View filing ↗
- MetLife, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in MetLife, Inc.'s own proxy. As printed: 22,364,273. View filing ↗
- Centene Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Centene Corporation's own proxy. As printed: 19,506,298. View filing ↗
- Humana, Inc., Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana, Inc.'s own proxy. As printed: 18,757,075. View filing ↗
- Molina Healthcare (subject), Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Molina Healthcare's own proxy. As printed: 18,340,783. View filing ↗
- DaVita Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in DaVita Inc.'s own proxy. As printed: 18,210,597. View filing ↗
- Becton, Dickinson and Company, Section 10b CEO total. DEF 14A, filed 2025-12-18. CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. View filing ↗
- Universal Health Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Universal Health Services, Inc.'s own proxy. As printed: 16,148,937. View filing ↗
- Quest Diagnostics Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. View filing ↗
- Prudential Financial, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Prudential Financial, Inc.'s own proxy. As printed: 11,408,423. View filing ↗
- Community Health Systems, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Community Health Systems, Inc.'s own proxy. As printed: 4,772,869. View filing ↗
- Section 10a, Universal Health Services, Inc. reciprocity. DEF 14A. Universal Health Services, Inc. names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Humana, Inc. reciprocity. DEF 14A. Humana, Inc. names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Centene Corporation reciprocity. DEF 14A. Centene Corporation names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Community Health Systems, Inc. reciprocity. DEF 14A. Community Health Systems, Inc. names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, DaVita Inc. reciprocity. DEF 14A. DaVita Inc. names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, HCA Healthcare, Inc. reciprocity. DEF 14A. HCA Healthcare, Inc. names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, The Cigna Group reciprocity. DEF 14A. The Cigna Group names Molina Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗